LCM
IMGO

Laurion Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Laurion Capital Management’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,000
Closed -$771K – 746
2022
Q1 		$771K Buy
+40,000
New +$830K 0.01% 268

Other funds holding IMGO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Laurion Capital Management's IMGO Position: Q2 2022 in Review

Laurion Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q2 2022, closing a stake of 40,000 shares — an estimated $771K sold.

Laurion Capital Management first reported a position in IMGO in Q1 2022 and held it in 1 quarter. The position peaked at $771K in Q1 2022. 62 funds tracked by Wall St. Rank hold IMGO as of Q2 2022.

  • Laurion Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q2 2022 after selling out during the quarter.
  • Laurion Capital Management sold 40,000 Imago BioSciences, Inc. Common stock shares in Q2 2022, an estimated $771K.
  • Laurion Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q1 2022 and held it in 1 quarter.
  • Laurion Capital Management's Imago BioSciences, Inc. Common stock position peaked at $771K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.